Category: CovidienSyndicate content

Going global: New AdvaMed chairman Almeida's focus on medtech harmony around the world

April 2, 2014 by Arezu Sarvestani

Covidien president & CEO AdvaMed board chairman Jose Almeida details his focus for his 2-year tenure as the chairman of the board for medtech lobbying group AdvaMed.

Harmony and ethics: New AdvaMed chairman Almeida's commitment to medtech

Incoming AdvaMed chairman Jose Almeida has an international outlook, planning to focus his 2-year leadership tenure on several goals that aim to reconcile initiatives in the U.S. with efforts overseas.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtech trends: The most talked about device makers in March 2014

April 2, 2014 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

Baxter reveals plans to split pharma, medical products businesses

March 27, 2014 by Brad Perriello

Baxter International says it plans to go the way of rivals Abbott and Covidien in splitting its pharmaceuticals and medical products businesses into separate companies.

Baxter reveals plans to split pharma, medical products businesses

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien chief Almeida to chair AdvaMed's board

March 26, 2014 by Arezu Sarvestani

Covidien chairman, president & CEO José Almeida is the new chairman of the board of directors at medtech lobbying group AdvaMed.

Covidien chief Almeida joins AdvaMed's board

Medtech lobbying group AdvaMed appointed a new board chairman, tapping Covidien (NYSE:COV) chairman, president & CEO José Almeida for the role.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien's Barrx ablation system stems progression of esophagus disease, study says

March 26, 2014 by Arezu Sarvestani

Covidien's Barrx RF ablation system bests watchful waiting in helping to curb the progression of Barrett's esophagus, a condition that can lead to esophageal cancer.

Covidien's Barrx ablation system stems progression of esophagus disease, study finds

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp